Page last updated: 2024-10-28

gyki 52466 and Benign Neoplasms, Brain

gyki 52466 has been researched along with Benign Neoplasms, Brain in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walczak, K1
Deneka-Hannemann, S1
Jarosz, B1
Zgrajka, W1
Stoma, F1
Trojanowski, T1
Turski, WA1
Rzeski, W1
Eyüpoglu, IY1
Hahnen, E1
Heckel, A1
Siebzehnrübl, FA1
Buslei, R1
Fahlbusch, R1
Blümcke, I1

Other Studies

2 other studies available for gyki 52466 and Benign Neoplasms, Brain

ArticleYear
Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:1

    Topics: Adult; Aged; Benzodiazepines; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation;

2014
Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.
    Journal of neurosurgery, 2005, Volume: 102, Issue:4

    Topics: Animals; Benzodiazepines; Brain Neoplasms; Cell Death; Cell Movement; Cell Proliferation; Dentate Gy

2005